Vincerx Pharma (NASDAQ:VINC) Enters into a Binding Term Sheet for Business Combination with Oqory, Inc.

Vincerx Pharma, Inc. filed an 8-K form with the Securities and Exchange Commission on December 20, 2024, announcing the entry into a binding term sheet with Oqory, Inc., a Delaware corporation, and Oqory’s parent company, Vivasor, Inc. This term sheet outlines a proposed business combination between Vincerx and Oqory, with an effective date of December […]

Leave a Reply

Your email address will not be published.

Previous post Timberwolves erase 15-point deficit in final five minutes to steal victory in Houston on Anthony Edwards’ late 3
Next post SPDR MSCI USA Climate Paris Aligned ETF (NASDAQ:NZUS) Short Interest Up 66.7% in December